125 related articles for article (PubMed ID: 37933140)
1. Practical gram-scale synthesis of bicyclol metabolites M2 and M3.
Ma B; Wang ZW; Liu XY; Wang MJ; Zhang YW; Zhang M; Jiao XZ; Xie P
J Asian Nat Prod Res; 2024 Mar; 26(3):342-352. PubMed ID: 37933140
[TBL] [Abstract][Full Text] [Related]
2. [Synthesis of metabolites of bicyclol].
Tang Y; Hu W; Li Y; Zhang CZ
Yao Xue Xue Bao; 2007 Oct; 42(10):1054-7. PubMed ID: 18229611
[TBL] [Abstract][Full Text] [Related]
3. Protective Effect of Bicyclol on Anti-Tuberculosis Drug Induced Liver Injury in Rats.
Liu X; Zhao M; Mi J; Chen H; Sheng L; Li Y
Molecules; 2017 Apr; 22(4):. PubMed ID: 28387740
[TBL] [Abstract][Full Text] [Related]
4. Comparison and identification of metabolic profiling of bicyclol in rats, dogs and humans in vitro and in vivo.
Hu M; Li Y; You F; Bai J; Fan X; Zhao S; Sun Y; Wang B; Hu J; Li Y
Eur J Pharm Sci; 2020 Nov; 154():105518. PubMed ID: 32818657
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of protective action of bicyclol against CCl-induced liver injury in mice.
Liu GT; Li Y; Wei HL; Zhang H; Xu JY; Yu LH
Liver Int; 2005 Aug; 25(4):872-9. PubMed ID: 15998439
[TBL] [Abstract][Full Text] [Related]
6. [Resolution of racemic anti-hepatitis drug ( +/- ) -bicyclol].
Hu W; Zhang CZ; Li Y
Yao Xue Xue Bao; 2006 Mar; 41(3):221-4. PubMed ID: 16758991
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Fas/FasL mRNA expression and TNF-alpha release in concanavalin A-induced liver injury in mice by bicyclol.
Li M; Liu GT
World J Gastroenterol; 2004 Jun; 10(12):1775-9. PubMed ID: 15188504
[TBL] [Abstract][Full Text] [Related]
8. A Multicenter and Randomized Controlled Trial of Bicyclol in the Treatment of Statin-Induced Liver Injury.
Naiqiong W; Liansheng W; Zhanying H; Yuanlin G; Chenggang Z; Ying G; Qian D; Dongchen L; Yanjun Z; Jianjun L
Med Sci Monit; 2017 Dec; 23():5760-5766. PubMed ID: 29200411
[TBL] [Abstract][Full Text] [Related]
9. Induction of heat shock protein 27 by bicyclol attenuates d-galactosamine/lipopolysaccharide-induced liver injury.
Dai HJ; Li DW; Wang YX; Sun AJ; Lu YX; Ding X; Zhang M; Song YG; Huang XD
Eur J Pharmacol; 2016 Nov; 791():482-490. PubMed ID: 27597162
[TBL] [Abstract][Full Text] [Related]
10. Effect of bicyclol on cisplatin-induced hepatotoxicity in the hepatocarcinoma 22 tumour-bearing mice.
Yu YN; Chen H; Li Y
Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):300-5. PubMed ID: 19210495
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice.
Wang H; Li Y
Eur J Pharmacol; 2006 Mar; 534(1-3):194-201. PubMed ID: 16487963
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of bicyclol for treating patients with idiosyncratic acute drug-induced liver injury: A multicenter, randomized, phase II trial.
Tang J; Gu J; Chu N; Chen Y; Wang Y; Xue D; Xie Q; Li L; Mei Z; Wang X; Li J; Chen J; Li Y; Yang C; Wang Y; Shang J; Xie W; Hu P; Li D; Zhao L; Lan P; Wang C; Chen C; Mao Y
Liver Int; 2022 Aug; 42(8):1803-1813. PubMed ID: 35567757
[TBL] [Abstract][Full Text] [Related]
13. Investigation on the
Chen F; Zou H; Zhang P; Yan Y
Xenobiotica; 2023 Apr; 53(4):231-240. PubMed ID: 37272731
[No Abstract] [Full Text] [Related]
14. [The protective effect of bicyclol on ischemia-reperfusion induced kidney injury in rats].
Zhao DM; Sun T; Li Y
Yao Xue Xue Bao; 2002 Jun; 37(6):412-4. PubMed ID: 12579794
[TBL] [Abstract][Full Text] [Related]
15. Induction of overexpression of the 27- and 70-kDa heat shock proteins by bicyclol attenuates concanavalin A-Induced liver injury through suppression of nuclear factor-kappaB in mice.
Bao XQ; Liu GT
Mol Pharmacol; 2009 May; 75(5):1180-8. PubMed ID: 19188336
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of bicyclol on tetracycline-induced fatty liver in mice.
Yu HY; Wang BL; Zhao J; Yao XM; Gu Y; Li Y
Toxicology; 2009 Jul; 261(3):112-8. PubMed ID: 19427351
[TBL] [Abstract][Full Text] [Related]
17. Bicyclol: a novel drug for treating chronic viral hepatitis B and C.
Liu GT
Med Chem; 2009 Jan; 5(1):29-43. PubMed ID: 19149648
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine.
Zhao T; Mao L; Yu Z; Hui Y; Feng H; Wang X; Lin L; Fan X; Chen X; Wang B; Cao X; Sun C
Int Immunopharmacol; 2021 Feb; 91():107308. PubMed ID: 33383448
[TBL] [Abstract][Full Text] [Related]
19. Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathways.
Zhao W; Yan Y; Xiao Z; Wang M; Xu M; Wang Z; Wang Y; Zhuang Z; Yang D; Chen G; Liang G
Biomed Pharmacother; 2021 Sep; 141():111874. PubMed ID: 34229251
[TBL] [Abstract][Full Text] [Related]
20. [Metabolism of bicyclol in rat and human liver microsomes in vitro].
Ju MH; Li Y
Yao Xue Xue Bao; 2005 Feb; 40(2):111-6. PubMed ID: 15875664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
